Literature DB >> 10630759

Current treatment strategies for rheumatoid arthritis.

E L Matteson1.   

Abstract

The management of rheumatoid arthritis has changed considerably during the past 15 years. Current strategies emphasize the need for early diagnosis and therapeutic intervention based on the use of disease-modifying antirheumatic drugs. The advent of agents that are more tailored to inhibit the specific disease processes will profoundly affect management. Immunogenetic studies may eventually assist in identifying subgroups of patients with rheumatoid arthritis who have more aggressive disease and who require a more aggressive treatment approach.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10630759     DOI: 10.4065/75.1.69

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  2 in total

1.  IL-1 beta- and IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA).

Authors:  A Kehlen; R Lauterbach; A N Santos; K Thiele; U Kabisch; E Weber; D Riemann; J Langner
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

2.  Effectiveness of sensorimotor training in patients with rheumatoid arthritis: a randomized controlled trial.

Authors:  Kelson Nonato Gomes da Silva; Lucas Emmanuel Pedro de Paiva Teixeira; Aline Mizusaki Imoto; Alvaro Nagib Atallah; Maria Stella Peccin; Virginia Fernandes Moça Trevisani
Journal:  Rheumatol Int       Date:  2013-03-03       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.